Max International

Max International no longer appears to be active as a direct sales company.

MaxGXL.com was tied to Max International, the Utah-based glutathione supplement MLM/direct-selling company. Max International is still active, but MaxGXL.com is no longer the company’s main public-facing brand site. The current consumer site is LiveMax.com, and MaxGXL is now one product within the broader Max International / LiveMax product line.

Original Npros business profile for Max International, preserved below for archival purposes:

Max International is a Utah-based nutritional supplement company originally formed as Max International, LLC on September 25, 2006. The company began operations in February 2007 in the glutathione nutraceutical market and became known for MaxGXL, an N-acetyl-cysteine-based glutathione-support supplement. Over time, the company expanded from the MaxGXL identity into a broader LiveMax / Max International wellness brand built around cellular health, glutathione support, antioxidant defense, energy, weight management, and healthy aging.

Max International's product line includes Cellgevity, MaxOne, MaxGXL, MaxATP, MaxN-Fuze, Switch, and Max357. MaxGXL remains one of the company's legacy products and is marketed as a proprietary NAC glutathione-enhancement formula. Cellgevity became the company's flagship product, built around patented RiboCeine technology, while MaxOne, MaxATP, MaxN-Fuze, and other products extend the line into cellular-health, energy, vitamin/mineral, and weight-management support.

Max International operated historically as a network-marketing/direct-selling company using independent Sales Associates. The company's current model is broader than the older MaxGXL-era opportunity: it sells and distributes products through direct-to-consumer e-commerce, healthcare professionals, affiliate and influencer sales, retail sales, and Sales Associates. Its current Associate materials still allow people to enroll as Max Associates or Preferred Customers, with a $25 one-time Business Activation fee and a $25 annual Virtual Office fee for Associates.

Max International remains active, but it has gone through a significant restructuring and repositioning. In October 2021, Venerable Holdings indirectly acquired a controlling interest in the company's ownership structure, and on February 16, 2023, the predecessor LLC converted into Max International, Inc. The company reported approximately 25,000 customers worldwide in the prior year, about 10,000 active Sales Associates in its historical business, and approximately 100 full-time employees worldwide. It also disclosed a strategic shift toward the U.S. market through e-commerce, retail, healthcare-professional channels, and other direct-to-consumer sales.

The company's recent financial filings show a materially smaller business than the older MaxGXL-era brand visibility might suggest. Max International reported revenue of $14.6 million in 2023, down from $25.5 million in 2022, with distributor incentives of $4.5 million in 2023 and $9.4 million in 2022. The company also reported a 2023 net loss of $9.05 million and disclosed that its auditor expressed doubt about its ability to continue as a going concern without additional fundraising or other funding sources.

Max International's legal history includes several disclosed business disputes rather than a major public FTC or FDA enforcement action. In its 2024 offering memorandum, the company disclosed pending litigation against former Chief Technology Officer Jeff Hanson and related parties seeking more than $1 million in damages, a 2019 Utah case against founder Steve Scott and others involving alleged non-compete, non-solicitation, contract, and trade-secret issues, and a New Zealand lease-guaranty dispute involving approximately NZ$79,000 plus interest and expenses.

Fred Ninow

Gregory Fullerton

Steve Scott